Reactogenicity in the elderly of nine commercial influenza vaccines: Results from the Italian SVEVA study

Vaccine

Volumn 17, Issue 15-16, 1999, Pages 1898-1904

  Spila Alegiani, Stefania ^a   Salmaso, Stefania ^a   Cristina Rota, Maria ^a   Eugenio Tozzi, Alberto ^a   Raschetti, Roberto ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Adverse events; Influence vaccines; Prospective study

Indexed keywords

INFLUENZA VACCINE; VIRUS VACCINE;

AGED; ARTICLE; CLINICAL TRIAL; FEMALE; FEVER; GERIATRIC PATIENT; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME; VIRUS INFECTION;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; HUMANS; INFLUENZA VACCINES; ITALY; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; SEX FACTORS; TIME FACTORS;

EID: 0033537949     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00467-8     Document Type: Article

References (16)

1. Nichol K.L., Margolis K.L., Wuorenma J., Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New Engl. J. Med. 331:1994;778-784.
2. Ministero della Sanità. Circolare ministeriale No. 10, 24 Luglio 1997.
3. D'Argenio P., Manfredi Selvaggi M.T., Ponzio G., Romano A., Pennino G., Greco D. La vaccinazione antinfluenzale tra gli anziani in 3 città dell'Italia meridionale. L'igiene Moderna. 103:1995;209-222.
4. EGRET. Statistics and Epidemiology Research Corporation, Seattle, WA. 1992-1993.
5. Ministero della Sanità Ufficio profilassi malattie infettive: statistiche relative al secondo semestre 1995. Bollettino epidemiologico. 11:1997;354.
6. Fedson D.S., Hirota Y., Shin H.K.et al. Influenza vaccination in 22 developed countries: an update to 1995. Vaccine. 15:1997;1506-1511.
7. van Haaren K.M., van den Brande K.J., Dekker F.W., Ligthart G.J., Spinger M.P. Influenza vaccine in 85-and-over aged: motivation of elderly and family physicians to vaccinate or not. Ned. Tijdschr. Geneeskd. 139:1995;2144-2148.
8. Honkanen P.O., Keistinen T., Kivela S.L. Factors associated with influenza coverage among the elderly: role of health care personnel. Public Health. 110:1996;163-168.
9. Nicholson K.G. Immunization against influenza among people aged over 65 living at home in Leicesterhire during winter 1991-1992. BMJ. 306:1993;974-976.
10. Roy G., Fradet M., Le Henaff D. Vaccination against influenza in elderly persons: some current presumptions. Can. J. Public Health. 87:1996;298-300.
11. Honkamen P.O., Keistinen T., Kivelä S.L. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. Arch. Intern. Med. 156:1996;205-208.
12. Margolis K.L., Nichol K.L., Poland G.A., Pluhar R.E. Frequency of adverse reactions to influenza vaccine in the elderly. JAMA. 264:1990;1139-1141.
13. Glathe H., Lange W. Influenza vaccination in older patients: immunogenicity, epidemiology and available agents. Drugs Ageing. 6:1995;368-387.
14. Nichol K.L., Margolis K.L., Lind A.et al. Side effects associated with influenza vaccination in healthy working adults: a randomised placebo-controlled trial. Arch. Intern. Med. 156:1996;1546-1550.
15. Govaert Th.M.E., Dinant G.J., Aretz K., Masurel N., Sprenger M.J.W., Knottnerus J.A. Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ. 307:1993;988-990.
16. Margolis K.L., Poland G.A., Nichol K.L., MacPherson D.S., Meyer J.D., Korn J.E., Lofgren R.P. Frequency of adverse reactions after influenza vaccination. Am. J. Med. 88:1990;27-30.